Top

Molecular Cancer

Published in:

Open Access 01-12-2019 | Magnetic Resonance Imaging | Review

Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues

Published in: Molecular Cancer | Issue 1/2019

Title: Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues
Publication date: 01-12-2019
Keywords: Magnetic Resonance Imaging
Magnetic Resonance Imaging
Bevacizumab
Published in: Molecular Cancer / Issue 1/2019
Electronic ISSN: 1476-4598
DOI: https://doi.org/10.1186/s12943-019-0950-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2019

Ai-lncRNA EGOT enhancing autophagy sensitizes paclitaxel cytotoxicity via upregulation of ITPR1 expression by RNA-RNA and RNA-protein interactions in human cancer

A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma

WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1

Surgical stress and cancer progression: the twisted tango

Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4

N6-methyladenosine (m6A) RNA modification in gastrointestinal tract cancers: roles, mechanisms, and applications

Keynote webinar | Spotlight on antibody–drug conjugates in cancer